ENTECAVIR PHARMASCIENCE INTERNATIONAL LTD 0.5mg tablets medication leaflet

J05AF10 entecavir • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Entecavir is an antiviral medication used to treat chronic hepatitis B, a viral infection that affects the liver. This medicine works by inhibiting the replication of the hepatitis B virus, helping to reduce inflammation and protect liver function. Entecavir is usually taken as tablets, once daily, as directed by the doctor.

Treatment with entecavir requires regular monitoring, as it is important to assess the effectiveness of the therapy and detect any side effects. Patients should strictly follow the treatment schedule and not stop taking the medication without medical advice.

Side effects may include headaches, fatigue, nausea, dizziness, or digestive disturbances. In rare cases, allergic reactions or impaired kidney function may occur.

Entecavir is an effective treatment for controlling chronic hepatitis B, but it requires constant medical supervision to prevent complications and ensure the success of the therapy. Collaboration with the doctor is essential throughout the treatment.

General data about ENTECAVIR PHARMASCIENCE INTERNATIONAL LTD 0.5mg

Substance: entecavir

Date of last drug list: 01-12-2017

Commercial code: W63920001

Concentration: 0.5mg

Pharmaceutical form: tablets

Quantity: 30

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for entecavir

Concentrations available for entecavir

0.05mg/ml, 0.5mg, 1mg